GlassScriptPhysician profile
Katherine Z Holcomb
NPI 1861668808
$411,401.11
in general payments reported to CMS, 2019-2025
46 companies · $54K in 2025
The $54K reported for 2025 was more than what 96% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $25K · 2021: $61K · 2022: $50K · 2023: $116K · 2024: $57K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $145K · Consulting Fee: $53K · Food and Beverage: $14K · Travel and Lodging: $14K · Education: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $144,757.80 |
| Consulting Fee | $52,945.08 |
| Food and Beverage | $14,497.63 |
| Travel and Lodging | $13,523.18 |
| Education | $410.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $139,406.91 | 2019-2025 | |
| Allergan, INC. | $118,513.07 | 2019-2023 | |
| Galderma Laboratories, L.P. | $118,398.07 | 2019-2025 | Aklief, Epsolay, Oracea |
| Almirall LLC | $10,341.52 | 2019-2025 | Seysara, Klisyri |
| Incyte Corporation | $8,207.41 | 2021-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $4,096.21 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $1,052.83 | 2019-2025 | Tremfya, Simponi, Stelara |
| Genzyme Corporation | $992.67 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $967.64 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $839.49 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| Pfizer INC. | $835.19 | 2019-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $823.35 | 2019-2024 | Jublia, Arazlo, Duobrii |
| Ucb, INC. | $784.16 | 2019-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $735.18 | 2019-2025 | Dupixent |
| Hill Dermaceuticals, INC. | $619.96 | 2023-2025 | Tolak |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $612.00 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $597.76 | 2019-2025 | |
| Leo Pharma INC. | $489.45 | 2019-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $454.09 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $389.44 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Biofrontera INC. | $329.83 | 2019-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Journey Medical Corporation | $298.38 | 2019-2025 | |
| Organon LLC | $289.72 | 2025 | Vtama |
| Amgen INC. | $279.25 | 2019-2025 | Otezla, Otezla |
| Dermira, INC. | $139.32 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $117.07 | 2019-2023 | Valchlor |
| Kyowa Kirin, INC. | $110.21 | 2021-2025 | |
| Dermavant Sciences, INC. | $101.30 | 2023-2024 | Vtama |
| Sanofi-Aventis U.S. LLC | $72.00 | 2022 | |
| Epi Health, LLC | $66.61 | 2019-2020 | |
| Vyne Pharmaceuticals INC. | $66.47 | 2020-2021 | |
| Verrica Pharmaceuticals INC. | $58.47 | 2023 | Ycanth |
| Botanix Sb INC | $50.10 | 2025 | Sofdra |
| Revance Therapeutics, INC. | $36.91 | 2025 | Daxxify |
| Genentech USA, INC. | $36.60 | 2021-2022 | |
| Medimetriks Pharmaceuticals, INC. | $35.32 | 2024-2025 | Clindacin Etz |
| Prugen, INC. Pharmaceuticals | $26.12 | 2020 | |
| Lumenis, INC | $20.04 | 2021 | |
| Aclaris Therapeutics, INC. | $19.31 | 2019 | |
| Strata Skin Sciences, INC. | $17.80 | 2023 | Xtrac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.27 | 2024 | Cyltezo |
| Mission Pharmacal Company | $16.07 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.43 | 2019 | |
| Ani Pharmaceuticals, INC. | $13.61 | 2023 | Apexicon E |
| Tactile Systems Technology INC | $12.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Holcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.